vs

Side-by-side financial comparison of ASHFORD HOSPITALITY TRUST INC (AHT) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

ASHFORD HOSPITALITY TRUST INC is the larger business by last-quarter revenue ($259.0M vs $186.7M, roughly 1.4× NEOGENOMICS INC). ASHFORD HOSPITALITY TRUST INC runs the higher net margin — -26.8% vs -57.9%, a 31.1% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs -6.0%). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs -7.7%).

Ashford Hospitality Trust Inc is a U.S.-headquartered real estate investment trust focused on upper-upscale full-service hotel properties across key U.S. urban, suburban and resort markets. Its portfolio holds assets under top global hospitality brands, serving business and leisure travelers, with a focus on long-term value growth and stable shareholder returns.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

AHT vs NEO — Head-to-Head

Bigger by revenue
AHT
AHT
1.4× larger
AHT
$259.0M
$186.7M
NEO
Growing faster (revenue YoY)
NEO
NEO
+17.1% gap
NEO
11.1%
-6.0%
AHT
Higher net margin
AHT
AHT
31.1% more per $
AHT
-26.8%
-57.9%
NEO
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
-7.7%
AHT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AHT
AHT
NEO
NEO
Revenue
$259.0M
$186.7M
Net Profit
$-69.3M
$-108.0M
Gross Margin
43.3%
Operating Margin
-2.6%
Net Margin
-26.8%
-57.9%
Revenue YoY
-6.0%
11.1%
Net Profit YoY
44.2%
42.0%
EPS (diluted)
$-12.85
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AHT
AHT
NEO
NEO
Q1 26
$186.7M
Q4 25
$259.0M
$190.2M
Q3 25
$266.1M
$187.8M
Q2 25
$302.0M
$181.3M
Q1 25
$277.4M
$168.0M
Q4 24
$275.5M
$172.0M
Q3 24
$276.6M
$167.8M
Q2 24
$316.5M
$164.5M
Net Profit
AHT
AHT
NEO
NEO
Q1 26
$-108.0M
Q4 25
$-69.3M
Q3 25
$-60.1M
$-27.1M
Q2 25
$-30.4M
$-45.1M
Q1 25
$-20.0M
$-25.9M
Q4 24
$-124.2M
Q3 24
$-57.9M
$-17.7M
Q2 24
$50.3M
$-18.6M
Gross Margin
AHT
AHT
NEO
NEO
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
AHT
AHT
NEO
NEO
Q1 26
Q4 25
-2.6%
-7.1%
Q3 25
4.6%
-14.4%
Q2 25
16.3%
-26.3%
Q1 25
22.2%
-16.6%
Q4 24
-17.8%
-10.7%
Q3 24
7.3%
-12.6%
Q2 24
42.8%
-13.3%
Net Margin
AHT
AHT
NEO
NEO
Q1 26
-57.9%
Q4 25
-26.8%
Q3 25
-22.6%
-14.4%
Q2 25
-10.1%
-24.9%
Q1 25
-7.2%
-15.4%
Q4 24
-45.1%
Q3 24
-20.9%
-10.5%
Q2 24
15.9%
-11.3%
EPS (diluted)
AHT
AHT
NEO
NEO
Q1 26
$-0.13
Q4 25
$-12.85
Q3 25
$-11.35
Q2 25
$-6.88
Q1 25
$-4.91
Q4 24
$-13.64
Q3 24
$-12.39
Q2 24
$2.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AHT
AHT
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$66.1M
$146.1M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$-626.4M
$828.8M
Total Assets
$2.8B
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AHT
AHT
NEO
NEO
Q1 26
$146.1M
Q4 25
$66.1M
$159.6M
Q3 25
$81.9M
$164.1M
Q2 25
$100.0M
$154.7M
Q1 25
$85.8M
$346.2M
Q4 24
$112.9M
$367.0M
Q3 24
$119.7M
$362.0M
Q2 24
$121.8M
$355.1M
Total Debt
AHT
AHT
NEO
NEO
Q1 26
Q4 25
$2.5B
$341.9M
Q3 25
$2.6B
Q2 25
$2.6B
Q1 25
$2.7B
Q4 24
$2.6B
$541.1M
Q3 24
$2.7B
Q2 24
$2.8B
Stockholders' Equity
AHT
AHT
NEO
NEO
Q1 26
$828.8M
Q4 25
$-626.4M
$836.6M
Q3 25
$-548.7M
$838.3M
Q2 25
$-485.5M
$854.0M
Q1 25
$-446.1M
$888.3M
Q4 24
$-419.2M
$902.3M
Q3 24
$-288.4M
$908.2M
Q2 24
$-225.9M
$915.9M
Total Assets
AHT
AHT
NEO
NEO
Q1 26
$1.3B
Q4 25
$2.8B
$1.4B
Q3 25
$3.0B
$1.4B
Q2 25
$3.1B
$1.4B
Q1 25
$3.1B
$1.6B
Q4 24
$3.2B
$1.6B
Q3 24
$3.3B
$1.6B
Q2 24
$3.3B
$1.6B
Debt / Equity
AHT
AHT
NEO
NEO
Q1 26
Q4 25
0.41×
Q3 25
Q2 25
Q1 25
Q4 24
0.60×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AHT
AHT
NEO
NEO
Operating Cash FlowLast quarter
$-15.7M
$-8.1M
Free Cash FlowOCF − Capex
$-86.8M
FCF MarginFCF / Revenue
-33.5%
Capex IntensityCapex / Revenue
27.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-135.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AHT
AHT
NEO
NEO
Q1 26
$-8.1M
Q4 25
$-15.7M
$1.3M
Q3 25
$5.5M
$8.9M
Q2 25
$16.3M
$20.3M
Q1 25
$-25.0M
$-25.3M
Q4 24
$-23.6M
$9.8M
Q3 24
$795.0K
$9.2M
Q2 24
$8.0M
$13.9M
Free Cash Flow
AHT
AHT
NEO
NEO
Q1 26
Q4 25
$-86.8M
$-6.5M
Q3 25
$-226.0K
$570.0K
Q2 25
$-3.6M
$14.0M
Q1 25
$-44.8M
$-29.8M
Q4 24
$-131.6M
$-1.8M
Q3 24
$-21.8M
$-1.6M
Q2 24
$-22.9M
$814.0K
FCF Margin
AHT
AHT
NEO
NEO
Q1 26
Q4 25
-33.5%
-3.4%
Q3 25
-0.1%
0.3%
Q2 25
-1.2%
7.7%
Q1 25
-16.2%
-17.8%
Q4 24
-47.8%
-1.0%
Q3 24
-7.9%
-0.9%
Q2 24
-7.2%
0.5%
Capex Intensity
AHT
AHT
NEO
NEO
Q1 26
Q4 25
27.5%
4.1%
Q3 25
2.1%
4.4%
Q2 25
6.6%
3.5%
Q1 25
7.2%
2.7%
Q4 24
39.2%
6.7%
Q3 24
8.2%
6.4%
Q2 24
9.8%
8.0%
Cash Conversion
AHT
AHT
NEO
NEO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AHT
AHT

Occupancy$190.2M73%
Food And Beverage$51.8M20%
Hotel Other$16.6M6%

NEO
NEO

Segment breakdown not available.

Related Comparisons